Medico speed up production of sampling swabs and virus transport mediums to help COVID-19 plague prevention

Recently, the global COVID-19 plague prevention is facing another severe test with the Delta Variant.   In the face of the rising demand for new crown testing, Medico has become “a little busy”.
In the 100000 level clean workshop, virus transport mediums and Specimen Collection Swabs used for nucleic acid detection are continuously coming off the production line. The workers, dressed in blue clean clothes, masks and disposable hoods, are working nervously and busily.

Liquid preparation, canning, pressure measurement, leak detection, labeling, supporting and packaging… With rigorous and detailed process flow, transparent sampling tubes injected with pink liquid are quickly off the line, packaged in plastic packaging and sent to all parts of the world.

To effectively cope with novel coronavirus pneumonia, to ensure the safety and health of the people. Nucleic acid detection sampling tubes and flocking swabs have also become one of the key emergency supplies for epidemic plague prevention. As a comprehensive high-tech biotechnology enterprise in China, Shenzhen Medico Technology Co., Ltd. produces a large number of flocked sampling swabs and “disposable virus sampling tubes” every day, with fire line reinforcement to help prevent and control the epidemic situation.

Since the emergence of the epidemic last year, Shenzhen Medico Technology Co., Ltd. has invested a lot of scientific research forces to tackle key technical problems. At present, the virus transport mediums and flocked swabs produced have played an important role in the new round of nucleic acid detection of epidemic plague prevention. Wang Xiaoping said that the “Virus transport mediums and flocked swabs produced by the enterprise have not only supported many domestic regions such as Nanjing, Yangzhou and Wuhan, but also exported to Europe, Vietnam, Indonesia, Malaysia and other countries.”

Medico has been supporting the global plague prevention of the new crown epidemic with excellent products. Next, Medico will further increase production capacity to ensure sufficient supply of nucleic acid testing materials.